Market Cap 540.71B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 21.02
Forward PE 19.49
Profit Margin 28.46%
Debt to Equity Ratio 0.46
Volume 2,230,420
Avg Vol 7,802,602
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 18%
Beta 0.27
Analysts Strong Sell
Price Target $259.92

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
TheUnmaker
TheUnmaker May. 8 at 4:19 PM
$TNXP I have a big gap in my teeth @ $59 that needs to be filled. Please and thank you in advance. $PFE $LLY $PG $JNJ
0 · Reply
FreeMoneyandFed
FreeMoneyandFed May. 8 at 4:12 PM
$SPY $QQQ $JNJ $MRNA Should have got into MRNA yesterday. saw it coming but didn't act !
0 · Reply
TheUnmaker
TheUnmaker May. 8 at 3:43 PM
$TNXP nice dip today.. glad to have bought more. $100+ stock after recent news. 35M+ new patients added to coverage is huge. $PFE $JNJ $LLY $PG
1 · Reply
Suite510
Suite510 May. 8 at 11:03 AM
$JNJ $KVUE $SPX $ABT baby issues 😂 'Do Not Use This Report': J&J Hid Asbestos Test, Jury Told Johnson & Johnson and a consultant it hired in the 1970s altered the conclusions of tests that found alarming levels of asbestos in the company's talc products before giving different results to the U.S. Food and Drug Administration, a former FDA commissioner told a Los Angeles jury Wednesday.
0 · Reply
peloswing
peloswing May. 8 at 5:09 AM
$JNJ Johnson & Johnson just broke down out of uptrend it has sustained since Summer 2025. Looking like the next support exists in the $210-213 area (shaded region), giving about ~$10 of room down in the short-term 🔻
0 · Reply
FreeMoneyandFed
FreeMoneyandFed May. 7 at 9:09 PM
$SPY $QQQ $JNJ $MRNA now they are starting the panic on hantavirus "contracted the virus on a pre-cruise birdwatching tour at a local landfill. " who the hell goes to a birdwatching tour to a landfill ? WTF?
3 · Reply
TCLutz
TCLutz May. 7 at 8:32 PM
$OSRH I got what I needed! Didn’t know they signed an NDA for their glucose monitor with china’s largest pharma distributor! 🤯💥 Don’t let the AH fxckery shake you out of your shares. This is typical conference manipulation. Gonna let it all ride! 💪🫡🔥 $SPY $JNJ $MRNA $PF.X
0 · Reply
DragonAlgoTrades
DragonAlgoTrades May. 7 at 4:34 AM
🐉 $JNJ CALL — DragonAlgo® Signal Contract: JNJ CALL Expiry: 2026-05-15 | Strike: $225.00 | Type: CALL Option Plan (premium): Entry: $3.02 Stop: $2.17 TP1: $3.93 TP2: $5.13 TP3: $7.25 🔗 https://dragonalgo.com
0 · Reply
Suite510
Suite510 May. 7 at 1:49 AM
$JNJ $KVUE $SPX 🤣😝
0 · Reply
Suite510
Suite510 May. 7 at 1:48 AM
$JNJ $KVUE $SPX Rut Ro legal boat to sink again 🤣 Ex-FDA Chief Testifies 100s Of JNJ Docs Tie Asbestos To Talc A former U.S. Food and Drug Administration commissioner on Tuesday testified in a Los Angeles bellwether trial over claims JNJ talc products caused deadly ovarian cancer in three women, saying hundreds of internal company documents reveal the company knew for decades that its talc contained asbestos.
0 · Reply
Latest News on JNJ
CVS to drop J&J's Stelara from its main formularies

May 5, 2026, 9:15 AM EDT - 3 days ago

CVS to drop J&J's Stelara from its main formularies

CVS


Why These 3 Forever Stocks Belong on Your Watchlist

Apr 28, 2026, 11:10 AM EDT - 10 days ago

Why These 3 Forever Stocks Belong on Your Watchlist

WMT XOM


J&J sees AI halving the time to generate drug development leads

Apr 27, 2026, 11:03 AM EDT - 11 days ago

J&J sees AI halving the time to generate drug development leads


Johnson & Johnson Transcript: AGM 2026

Apr 23, 2026, 10:00 AM EDT - 15 days ago

Johnson & Johnson Transcript: AGM 2026


Johnson & Johnson CFO on the company's robotic surgical system

Apr 14, 2026, 10:51 AM EDT - 24 days ago

Johnson & Johnson CFO on the company's robotic surgical system


Johnson & Johnson Earnings Call Transcript: Q1 2026

Apr 14, 2026, 8:30 AM EDT - 24 days ago

Johnson & Johnson Earnings Call Transcript: Q1 2026


J&J raises guidance for 2026 on strong start to the year

Apr 14, 2026, 6:55 AM EDT - 24 days ago

J&J raises guidance for 2026 on strong start to the year


Johnson & Johnson reports Q1 2026 results, raises 2026 outlook

Apr 14, 2026, 6:20 AM EDT - 24 days ago

Johnson & Johnson reports Q1 2026 results, raises 2026 outlook


J&J's First-Quarter Sales Grow on Cancer-Drug Strength

Apr 14, 2026, 6:20 AM EDT - 24 days ago

J&J's First-Quarter Sales Grow on Cancer-Drug Strength


The Big 3: ORCL, JNJ, SBUX

Mar 19, 2026, 1:00 PM EDT - 7 weeks ago

The Big 3: ORCL, JNJ, SBUX

ORCL SBUX


US FDA approves J&J's oral psoriasis pill

Mar 18, 2026, 8:31 AM EDT - 7 weeks ago

US FDA approves J&J's oral psoriasis pill


US FDA approves JNJ's blood cancer drug

Mar 5, 2026, 2:21 PM EST - 2 months ago

US FDA approves JNJ's blood cancer drug


Johnson & Johnson launches website for direct-to-consumer sales

Mar 4, 2026, 6:07 PM EST - 2 months ago

Johnson & Johnson launches website for direct-to-consumer sales


TheUnmaker
TheUnmaker May. 8 at 4:19 PM
$TNXP I have a big gap in my teeth @ $59 that needs to be filled. Please and thank you in advance. $PFE $LLY $PG $JNJ
0 · Reply
FreeMoneyandFed
FreeMoneyandFed May. 8 at 4:12 PM
$SPY $QQQ $JNJ $MRNA Should have got into MRNA yesterday. saw it coming but didn't act !
0 · Reply
TheUnmaker
TheUnmaker May. 8 at 3:43 PM
$TNXP nice dip today.. glad to have bought more. $100+ stock after recent news. 35M+ new patients added to coverage is huge. $PFE $JNJ $LLY $PG
1 · Reply
Suite510
Suite510 May. 8 at 11:03 AM
$JNJ $KVUE $SPX $ABT baby issues 😂 'Do Not Use This Report': J&J Hid Asbestos Test, Jury Told Johnson & Johnson and a consultant it hired in the 1970s altered the conclusions of tests that found alarming levels of asbestos in the company's talc products before giving different results to the U.S. Food and Drug Administration, a former FDA commissioner told a Los Angeles jury Wednesday.
0 · Reply
peloswing
peloswing May. 8 at 5:09 AM
$JNJ Johnson & Johnson just broke down out of uptrend it has sustained since Summer 2025. Looking like the next support exists in the $210-213 area (shaded region), giving about ~$10 of room down in the short-term 🔻
0 · Reply
FreeMoneyandFed
FreeMoneyandFed May. 7 at 9:09 PM
$SPY $QQQ $JNJ $MRNA now they are starting the panic on hantavirus "contracted the virus on a pre-cruise birdwatching tour at a local landfill. " who the hell goes to a birdwatching tour to a landfill ? WTF?
3 · Reply
TCLutz
TCLutz May. 7 at 8:32 PM
$OSRH I got what I needed! Didn’t know they signed an NDA for their glucose monitor with china’s largest pharma distributor! 🤯💥 Don’t let the AH fxckery shake you out of your shares. This is typical conference manipulation. Gonna let it all ride! 💪🫡🔥 $SPY $JNJ $MRNA $PF.X
0 · Reply
DragonAlgoTrades
DragonAlgoTrades May. 7 at 4:34 AM
🐉 $JNJ CALL — DragonAlgo® Signal Contract: JNJ CALL Expiry: 2026-05-15 | Strike: $225.00 | Type: CALL Option Plan (premium): Entry: $3.02 Stop: $2.17 TP1: $3.93 TP2: $5.13 TP3: $7.25 🔗 https://dragonalgo.com
0 · Reply
Suite510
Suite510 May. 7 at 1:49 AM
$JNJ $KVUE $SPX 🤣😝
0 · Reply
Suite510
Suite510 May. 7 at 1:48 AM
$JNJ $KVUE $SPX Rut Ro legal boat to sink again 🤣 Ex-FDA Chief Testifies 100s Of JNJ Docs Tie Asbestos To Talc A former U.S. Food and Drug Administration commissioner on Tuesday testified in a Los Angeles bellwether trial over claims JNJ talc products caused deadly ovarian cancer in three women, saying hundreds of internal company documents reveal the company knew for decades that its talc contained asbestos.
0 · Reply
bbq1232
bbq1232 May. 6 at 3:42 PM
$JNJ wild at this point. No love
0 · Reply
biotech
biotech May. 6 at 1:59 PM
$SGMO MAY 12 3:30-5pm 𝙜𝙚𝙣𝙚 𝙚𝙙𝙞𝙩𝙞𝙣𝙜 𝙨𝙚𝙨𝙨𝙞𝙤𝙣 on 𝙉𝙚𝙭𝙩-𝙜𝙚𝙣𝙚𝙧𝙖𝙩𝙞𝙤𝙣 𝙥𝙡𝙖𝙩𝙛𝙤𝙧𝙢𝙨 𝙛𝙤𝙧 𝙥𝙧𝙚𝙘𝙞𝙨𝙚 𝙩𝙝𝙚𝙧𝙖𝙥𝙚𝙪𝙩𝙞𝙘 𝙜𝙚𝙣𝙤𝙢𝙚 𝙚𝙙𝙞𝙩𝙞𝙣𝙜 𝙖𝙣𝙙 𝙞𝙣𝙩𝙚𝙜𝙧𝙖𝙩𝙞𝙤𝙣 #MINT for next genereation CAR-T $GILD $NVS $JNJ $BMY
0 · Reply
clan
clan May. 6 at 12:46 PM
$MNKD $JNJ @DRFSR @pierrules For the good of all Mannkind, MNKD-1501 announced as Technoralinepagosphere DPI deserves a ...
0 · Reply
TheUnmaker
TheUnmaker May. 6 at 11:30 AM
$TNXP We are just getting started.. Easily going to $30+ very fast! $LLY $JNJ $PG $PFE
0 · Reply
Quantumup
Quantumup May. 6 at 11:12 AM
Stifel y'day⬆️ $SYRE's PT to $107 (was $92), reit'd at Buy/said: Following best-in-class UC PoC data for SPY001 (α4β7), SYRE is well-positioned heading into additional PoC cohorts for SPY002 (TL1A) and SPY003 (IL-23p19) in mid-year/3Q26. $JNJ TAK APGE ABVX $ABBV Here's what else Stifel had to say: https://x.com/Quantumup1/status/2051982840607215753?s=20
0 · Reply
TheUnmaker
TheUnmaker May. 6 at 11:03 AM
$TNXP We will run now.. she's ready! $PFE $NVAX $LLY $JNJ
0 · Reply
DragonAlgoTrades
DragonAlgoTrades May. 6 at 10:19 AM
🐉 $JNJ PUT — DragonAlgo® Signal Contract: JNJ PUT Expiry: 2026-05-15 | Strike: $225.00 | Type: PUT Option Plan (premium): Entry: $2.77 Stop: $1.99 TP1: $3.60 TP2: $4.71 TP3: $6.65 🔗 https://dragonalgo.com
0 · Reply
TheUnmaker
TheUnmaker May. 5 at 6:57 PM
$TNXP Bring in the apes! $PFE $NBIS $LLY $JNJ
1 · Reply
RiskyAlpha
RiskyAlpha May. 5 at 3:05 PM
$QQQ $JNJ Starting the day with a wide 4-leg parlay.
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER May. 5 at 3:03 PM
$BSX just buy the dips and sell the stall areas to build out positions in the device makers as the $IHI begins to find its footing for some upside action $MDT $DHR $JNJ and plenty of others
0 · Reply
Framingtheworld
Framingtheworld May. 5 at 2:10 PM
$ATAI q2 is the expected timeline of a $2 billion partnership with possibly companies like $JNJ
2 · Reply
DragonAlgoTrades
DragonAlgoTrades May. 5 at 1:26 PM
🐉 $JNJ CALL — DragonAlgo® Signal Contract: JNJ CALL Expiry: 2026-05-08 | Strike: $225.00 | Type: CALL Option Plan (premium): Entry: $2.16 Stop: $1.56 TP1: $2.81 TP2: $3.67 TP3: $5.18 🔗 https://dragonalgo.com
0 · Reply